Measuring unadulterated whole blood viscosity in patients with familial hypercholesterolemia on long-term LDL apheresis

被引：0
|
作者：
Moriarty, PM
Gibson, CA
Kensey, KR
Hogenauer, WN
机构：
[1] Univ Kansas, Sch Med, Kansas City, KS USA
[2] Rheol Inc, Exton, PA USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2002年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P269
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [41] Trial Assessing Long-Term Use of PCSK9 Inhibition in Patients with Genetic LDL Disorders (TAUSSIG): Efficacy and Safety in Patients with Homozygous Familial Hypercholesterolemia Receiving Lipid Apheresis
    Bruckert, Eric
    Blaha, Vladimir
    Stein, Evan A.
    Real, Frederick J.
    Kurtz, Christopher E.
    Honarpour, Narimon
    Xu, Feng
    Gibbs, John
    Wasserman, Scott M.
    Scott, Rob
    Couture, Patrick
    CIRCULATION, 2014, 130
  • [42] PREGNANCY IN A PATIENT WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA TREATED WITH LONG-TERM LOW-DENSITY-LIPOPROTEIN APHERESIS
    KROON, AA
    SWINKELS, DW
    VANDONGEN, PWJ
    STALENHOEF, AFH
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (09): : 1164 - 1170
  • [43] Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial Hypercholesterolemia
    Hudgins, Lisa C.
    Kleinman, Bryan
    Scheuer, Abby
    White, Sharon
    Gordon, Bruce R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (09): : 1199 - 1204
  • [44] LONG-TERM EFFECTS OF ILEAL BYPASS ON LIPOPROTEINS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    KOIVISTO, P
    MIETTINEN, TA
    CIRCULATION, 1984, 70 (02) : 290 - 296
  • [45] The Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
    Raal, Frederick J.
    Rosenson, Robert S.
    Reeskamp, Rens
    Kastelein, John J.
    Rubba, Paolo
    Duell, Bart
    Koseki, Masahiro
    Stroes, Erik S.
    Ali, Shazia
    Banerjee, Poulabi
    Chan, KuoChen
    Khilla, Nagwa
    McGinniss, Jennifer
    Pordy, Robert
    Zhang, Yi
    Gaudet, Daniel
    CIRCULATION, 2021, 144
  • [46] Long-term effect of low-density lipoprotein apheresis: Experience in four children with familial homozygous hypercholesterolemia
    Hasanoglu, A.
    Yenicesu, I
    Eminoglu, F. T.
    Okur, I
    Tumer, L.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 127 - 127
  • [47] Insufficient long-term LDL-cholesterol management in patients with familial hypercholesterolemia 5 years after an acute coronary syndrome
    Krasieva, K.
    Gencer, B.
    Carballo, D.
    Muller, O.
    Fournier, S.
    Matter, C.
    Luescher, T.
    Raeber, L.
    Rodondi, N.
    Mach, F.
    Nanchen, D.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [48] Long-term outcome of liver transplantation for familial hypercholesterolemia
    Shrotri, M
    Fernando, BS
    Sudhindran, S
    Delriviere, L
    Watson, CJ
    Gibbs, P
    Alexander, GJ
    Gimson, AE
    Jamieson, NV
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (01) : 381 - 382
  • [49] Results of intensive long-term treatment of familial hypercholesterolemia
    Retterstol, K
    Stugaard, M
    Gorbitz, C
    Ose, L
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (12): : 1369 - 1374
  • [50] Real-world experience of long-term efficacy and safety of evinacumab in patients with homozygous familial hypercholesterolemia treated and untreated with lipoprotein apheresis
    Stefanutti, Claudia
    Chan, Dick C.
    Zeppa, Giovanna
    Watts, Gerald F.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (05) : e817 - e824
12345